Scribe Therapeutics, Inc. ($SCTX)
Filing Information
| Accession Number | 0001231919-26-000813 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 29, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
19,364,072
Total Value
$4,999,995.00
P&L
+22.4% (+$1,119,998.88)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Jul 27, 2026 | Conversion | 2,051,742 | โ | โ | 2,051,742 | Indirect | By AH Bio Fund II, L.P. | View Details | |
10% Owner | Common Stock | โ | Jul 27, 2026 | Conversion | 697,650 | โ | โ | 697,650 | Indirect | By AH Bio Fund III, L.P. | View Details | |
10% Owner | Common Stock | โ | Jul 27, 2026 | Purchase | 333,333 | $15.00 | $4,999,995.00 | 2,385,075 | Indirect | By AH Bio Fund II, L.P. | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Jul 27, 2026 | Conversion | 12,150,003 | $0.00 | $0.00 | 0 | Indirect | By AH Bio Fund II, L.P. | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Jul 27, 2026 | Conversion | 4,131,344 | $0.00 | $0.00 | 0 | Indirect | By AH Bio Fund III, L.P. | View Details |